AI assistant
AGENUS INC — Director's Dealing 2012
Dec 27, 2012
34023_dirs_2012-12-27_bef5f7b9-a771-4374-b6dc-431f14182948.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2012-12-24
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-24 | Common Stock | J | 250277 | $4.33 | Acquired | 913473 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 796168 | Indirect |
Footnotes
F1: Distribution from Armen Partners LP. Dr. Armen is the General Partner of Armen Partners LP.
F2: Dr. Armen is trustee and has investment authority for the Garo Armen 2009 4 year GRAT and the Garo Armen 2 Year GRAT, each holding 292,122 and 500,000 shares of Agenus Inc. common stock, respectively. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership of his pecuniary interest therein.